ACCESSION: MSBNK-SMB_Measured-HSA014P0381000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 48
COMMENT: RAW_SPEC {'Blanc1-neg_9579': {'bp': 7977715.0, 'sum': 21433552.0}, 'Blanc1-neg_9622': {'bp': 6322484.0, 'sum': 16353964.0}, 'EL14-neg_9308': {'bp': 558079.0, 'sum': 1801575.0}, 'EL24-neg_9282': {'bp': 481796.0, 'sum': 1649403.0}, 'EL19-neg_9363': {'bp': 460235.0, 'sum': 1505583.0}, 'EL20-neg_9331': {'bp': 456545.0, 'sum': 1520994.0}, 'EL17-neg_9328': {'bp': 451395.0, 'sum': 1489627.0}, 'EL16-neg_9306': {'bp': 432960.0, 'sum': 1485022.0}, 'EL11-neg_9298': {'bp': 411316.0, 'sum': 1457803.0}, 'EL05-neg_9353': {'bp': 401323.0, 'sum': 1366787.0}, 'EL22-neg_9374': {'bp': 394734.0, 'sum': 1359163.0}, 'EL12-neg_9352': {'bp': 392968.0, 'sum': 1359022.0}, 'EL18-neg_9313': {'bp': 386882.0, 'sum': 1314188.0}, 'EL13-neg_9309': {'bp': 380731.0, 'sum': 1371153.0}, 'EL04-neg_9289': {'bp': 378157.0, 'sum': 1363516.0}, 'EL03-neg_9301': {'bp': 377819.0, 'sum': 1385391.0}, 'EL08-neg_9343': {'bp': 331978.0, 'sum': 1277575.0}, 'EL21-neg_9352': {'bp': 321447.0, 'sum': 1212692.0}, 'EL09-neg_9318': {'bp': 319341.0, 'sum': 1236473.0}, 'EL02-neg_9384': {'bp': 317969.0, 'sum': 1181400.0}, 'EL15-neg_9331': {'bp': 304600.0, 'sum': 1113317.0}, 'EL02-neg_9417': {'bp': 304559.0, 'sum': 1140973.0}, 'EL23-neg_9339': {'bp': 290587.0, 'sum': 1140492.0}, 'EL06-neg_9377': {'bp': 286129.0, 'sum': 1111142.0}, 'Blanc3-neg_9257': {'bp': 272658.0, 'sum': 1179227.0}, 'EL10-neg_9302': {'bp': 265911.0, 'sum': 1146048.0}, 'EL23-neg_9307': {'bp': 259668.0, 'sum': 1041370.0}, 'EL21-neg_9319': {'bp': 258195.0, 'sum': 1036983.0}, 'EL10-neg_9335': {'bp': 255461.0, 'sum': 1096618.0}, 'EL06-neg_9343': {'bp': 251808.0, 'sum': 995454.0}, 'EL07-neg_9316': {'bp': 251302.0, 'sum': 1021906.0}, 'EL12-neg_9386': {'bp': 246155.0, 'sum': 1006921.0}, 'EL15-neg_9366': {'bp': 239655.0, 'sum': 956734.0}, 'EL01-neg_9332': {'bp': 236167.0, 'sum': 1062201.0}, 'Blanc2-neg_9290': {'bp': 234754.0, 'sum': 1055903.0}, 'EL04-neg_9321': {'bp': 234491.0, 'sum': 1056070.0}, 'EL08-neg_9310': {'bp': 231357.0, 'sum': 1010700.0}, 'EL07-neg_9351': {'bp': 217152.0, 'sum': 934817.0}, 'EL05-neg_9388': {'bp': 212468.0, 'sum': 935185.0}, 'Blanc3-neg_9291': {'bp': 209325.0, 'sum': 982771.0}, 'EL17-neg_9363': {'bp': 207841.0, 'sum': 897025.0}, 'EL01-neg_9297': {'bp': 207315.0, 'sum': 965016.0}, 'EL22-neg_9411': {'bp': 204104.0, 'sum': 875473.0}, 'EL09-neg_9353': {'bp': 201816.0, 'sum': 888912.0}, 'EL19-neg_9398': {'bp': 197835.0, 'sum': 886846.0}, 'EL16-neg_9341': {'bp': 182139.0, 'sum': 840796.0}, 'EL13-neg_9344': {'bp': 180497.0, 'sum': 901288.0}, 'EL20-neg_9366': {'bp': 179878.0, 'sum': 848097.0}}
COMMENT: RETENTION_TIME_STDEV 0.032
COMMENT: PRECURSOR_M/Z_RAW 381.231537
COMMENT: PRECURSOR_M/Z_STDEV 0.000179
COMMENT: PRECURSOR_IN_MS1 mz 381.231494; int 108.583; delta(ppm) 1.146941
COMMENT: PROPOSED_CHARGE_STATE -1; mz 382.234850; int 23.118; cor 0.942
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.694; C18H40O4P2; [M-H]1; delta(ppm) -3.694026
COMMENT: PROPOSED_MF SevenGoldenRules 0.628; C20H35N2O3P; [M-H]1; delta(ppm) 0.627880
COMMENT: PROPOSED_MF SevenGoldenRules 4.950; C22H30N4O2; [M-H]1; delta(ppm) 4.949786
COMMENT: PROPOSED_MF MS-FINDER 2.556; C18H40O4P2; [M-H]-; delta(ppm) -3.702021
COMMENT: PROPOSED_MF MS-FINDER 2.516; C22H30N4O2; [M-H]-; delta(ppm) 4.963417
COMMENT: PROPOSED_MF MS-FINDER 2.512; C20H35N2O3P; [M-H]-; delta(ppm) 0.630679
COMMENT: PROPOSED_MF MS-FINDER 2.353; C11H38N6O4S2; [M-H]-; delta(ppm) -2.170101
COMMENT: PROPOSED_MF MS-FINDER 2.314; C18H38O6S; [M-H]-; delta(ppm) -0.371198
COMMENT: PROPOSED_MF MS-FINDER 2.133; C19H34N4O2S; [M-H]-; delta(ppm) -3.879324
COMMENT: PROPOSED_MF MS-FINDER 2.044; C15H30N10S; [M-H]-; delta(ppm) 3.164494
COMMENT: PROPOSED_MF MS-FINDER 2.003; C11H30N10O5; [M-H]-; delta(ppm) -3.398735
COMMENT: PROPOSED_MF MS-FINDER 1.955; C19H42OS3; [M-H]-; delta(ppm) -2.650692
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.806; C20H38O3Si2; [M-H]-; delta(ppm) -143632.589986
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.399; C18H38O6S; [M-H]-; delta(ppm) -0.371198
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.647; C14H34N6O4S; [M-H]-; delta(ppm) 6.672670
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.985; C18H36ClFN2O3; [M-H]-; delta(ppm) -59227.915573
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.285; C16H36N3O5S; [M-H]-; delta(ppm) 3.150724
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.551; C21H35ClN2O2; [M-H]-; delta(ppm) -59225.262825
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.399; C21H34O6; [M-H]-; delta(ppm) 8.471605
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.583; C22H30N4O2; [M-H]-; delta(ppm) 4.963417
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.929; C20H35N2O3P; [M-H]-; delta(ppm) 0.630679
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.731; C18H35FO7; [M-H]-; delta(ppm) 5.474293
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.696; C18H38O6S; [M-H]-; delta(ppm) -0.371198
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.302; C14H34N6O4S; [M-H]-; delta(ppm) 6.672670
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C16H36N3O5S; [M-H]-; delta(ppm) 3.150724
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.391; VLXJANUFVJNWKB-DYDAYEHQNA-N; [M-H]-; CC[C@@H]1C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@H](C)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.341; ZYKOCHZYVSYMDU-UHFFFAOYSA-N; [M-H]-; O(CCC)CC1OC2OC3(OC2C4OC5(OC14)CCCCC5)CCCCC3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.337; JTFGPTHCAAUOQL-REAMHEGWNA-N; [M-H]-; CC[C@H](CO)[C@H]1[C@@](C)(O)[C@]2(O)[C@@H]3C[C@](C)(O)C[C@@H](C)[C@@H]3[C@@]1(C)C(=O)\C2=C/O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.332; KRJHGNYSGWSYLV-PKNGOHSSNA-N; [M-H]-; CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](O)C[C@H]1[C@@]3(C)CC[C@H](O)C[C@@H]3CC[C@@]21O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.328; AHIGXABPPZEAPK-GMGGTNBPNA-N; [M-H]-; C[C@@H](O)[C@H]1CC[C@]2(O)[C@@H]3CC=C4C[C@@H](O)CC[C@]4(CO)[C@H]3[C@H](O)[C@@H](O)[C@]12C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.361; NJDBZBVQIMZWPP-UHFFFAOYSA-N; [M-H]-; 3-(2-methylpyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)nonanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.343; QCWJONLQSHEGEJ-UHFFFAOYSA-N; [M-H]-; tetrofosmin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.304; AYEPZVLFDVMBNI-UHFFFAOYSA-N; [M-H]-; [5-(1-methyl-3-phenyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl N-(propan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.293; PTJSAWWFMQJYSI-UHFFFAOYSA-N; [M-H]-; [5-(1-methyl-3-phenyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.289; INGUXUFDBQIFBA-UHFFFAOYSA-N; [M-H]-; N-({5-[6-(furan-2-yl)-2-methylpyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.273; VFDCJOLMWUQVJV-UHFFFAOYSA-N; [M-H]-; 1-(4-methoxyphenyl)-5-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.266; MSQBSCJYDOTBEL-UHFFFAOYSA-N; [M-H]-; 1-(4-methylpiperazin-1-yl)-2-{3-[(5-phenyl-1,2-oxazol-3-yl)methyl]piperidin-4-yl}ethan-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.264; GBOLAHXSUSFXOQ-UHFFFAOYSA-N; [M-H]-; N-({5-[6-(furan-2-yl)-2-methylpyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.263; FABJAUUGNRAJRD-UHFFFAOYSA-N; [M-H]-; N-{[5-(3-cyclopentyl-1-methyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl}furan-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.255; HOADLWZAKRJASE-UHFFFAOYSA-N; [M-H]-; 3-{1-methyl-6-[(4-methylphenyl)methyl]-5-oxo-decahydropyrrolo[3,2-e][1,4]diazepin-2-yl}-N-(prop-2-yn-1-yl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.254; SXORXEDYBXYZMG-UHFFFAOYNA-N; [M-H]-; 3-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]-N-[2-(2-methyl-1-piperidinyl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.250; IAFYNFFDTUUFOL-UHFFFAOYSA-N; [M-H]-; 4-(cyclohexylamino)-2-(hydroxymethyl)-3-{[2-(pyridin-3-yl)pyrimidin-4-yl]methyl}cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; QSOPFYWXWAZOMQ-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]quinoxaline-6-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; GVSGTFNQYPQSJK-UHFFFAOYSA-N; [M-H]-; 3-(4-methoxyphenyl)-1-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; OJCSZXRGAQMWEK-UHFFFAOYSA-N; [M-H]-; 3-(2-methoxyphenyl)-1-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.240; CQEABHXMZGKDIQ-UHFFFAOYSA-N; [M-H]-; N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.240; FFEYSIPRSWWECA-UHFFFAOYSA-N; [M-H]-; N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.240; WOAQLSGWXMUQMS-UHFFFAOYSA-N; [M-H]-; N-cyclopropyl-2-{3-[(5-{[methyl(phenyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.239; HGHIKYSUAQJXSW-UHFFFAOYSA-N; [M-H]-; N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-3-(4-oxo-3,4-dihydroquinazolin-3-yl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.230; KOBQJPWUSUOEJQ-UHFFFAOYSA-N; [M-H]-; 1-ethyl-7-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.222; BUDHMTPSPADVKZ-UHFFFAOYSA-N; [M-H]-; N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-(3-phenyl-1,2,4-oxadiazol-5-yl)butanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.218; FXYDKLZRIUEGDD-UHFFFAOYSA-N; [M-H]-; 1-(4-acetylphenyl)-3-[(5-{[methyl(prop-2-yn-1-yl)amino]methyl}-1-azabicyclo[2.2.2]octan-2-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.201; GFRVNDBWOSRHOR-UHFFFAOYSA-N; [M-H]-; N-benzyl-6-[4-(cyclohexylmethyl)-1H-1,2,3-triazol-1-yl]-hexahydrofuro[3,2-b]furan-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.126; VZVBPKHDCHCPJY-UHFFFAOYSA-N; [M-H]-; N-{[5-({methyl[2-(pyridin-2-yl)ethyl]amino}methyl)-1-azabicyclo[2.2.2]octan-2-yl]methyl}furan-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.117; NZNAOBRVCLBIHB-UHFFFAOYSA-N; [M-H]-; 4-[3-(diethylamino)propyl]-2-methyl-4,7,17-triazatetracyclo[8.7.0.0?,?.0??,??]heptadeca-1(10),11,13,15-tetraene-3,6-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.089; KTVATEBHFLZLCI-UHFFFAOYSA-N; [M-H]-; N,N''-hexane-1,6-diylbis[N'-benzylurea]
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FXYDKLZRIUEGDD-UHFFFAOYSA-N; [M-H]-; 1-(4-acetylphenyl)-3-[(5-{[methyl(prop-2-yn-1-yl)amino]methyl}-1-azabicyclo[2.2.2]octan-2-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; MSQBSCJYDOTBEL-UHFFFAOYSA-N; [M-H]-; 1-(4-methylpiperazin-1-yl)-2-{3-[(5-phenyl-1,2-oxazol-3-yl)methyl]piperidin-4-yl}ethan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.681; WOAQLSGWXMUQMS-UHFFFAOYSA-N; [M-H]-; N-cyclopropyl-2-{3-[(5-{[methyl(phenyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; BUDHMTPSPADVKZ-UHFFFAOYSA-N; [M-H]-; N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-(3-phenyl-1,2,4-oxadiazol-5-yl)butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; CQEABHXMZGKDIQ-UHFFFAOYSA-N; [M-H]-; N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; FFEYSIPRSWWECA-UHFFFAOYSA-N; [M-H]-; N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; GVSGTFNQYPQSJK-UHFFFAOYSA-N; [M-H]-; 3-(4-methoxyphenyl)-1-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; HGHIKYSUAQJXSW-UHFFFAOYSA-N; [M-H]-; N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-3-(4-oxo-3,4-dihydroquinazolin-3-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; HOADLWZAKRJASE-UHFFFAOYSA-N; [M-H]-; 3-{1-methyl-6-[(4-methylphenyl)methyl]-5-oxo-decahydropyrrolo[3,2-e][1,4]diazepin-2-yl}-N-(prop-2-yn-1-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; KOBQJPWUSUOEJQ-UHFFFAOYSA-N; [M-H]-; 1-ethyl-7-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; OJCSZXRGAQMWEK-UHFFFAOYSA-N; [M-H]-; 3-(2-methoxyphenyl)-1-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; QSOPFYWXWAZOMQ-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]quinoxaline-6-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; VFDCJOLMWUQVJV-UHFFFAOYSA-N; [M-H]-; 1-(4-methoxyphenyl)-5-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.620; AYEPZVLFDVMBNI-UHFFFAOYSA-N; [M-H]-; [5-(1-methyl-3-phenyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl N-(propan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.620; PTJSAWWFMQJYSI-UHFFFAOYSA-N; [M-H]-; [5-(1-methyl-3-phenyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.600; NJDBZBVQIMZWPP-UHFFFAOYSA-N; [M-H]-; 3-(2-methylpyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)nonanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.553; SXORXEDYBXYZMG-UHFFFAOYNA-N; [M-H]-; 3-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]-N-[2-(2-methyl-1-piperidinyl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.538; GFRVNDBWOSRHOR-UHFFFAOYSA-N; [M-H]-; N-benzyl-6-[4-(cyclohexylmethyl)-1H-1,2,3-triazol-1-yl]-hexahydrofuro[3,2-b]furan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.520; VZVBPKHDCHCPJY-UHFFFAOYSA-N; [M-H]-; N-{[5-({methyl[2-(pyridin-2-yl)ethyl]amino}methyl)-1-azabicyclo[2.2.2]octan-2-yl]methyl}furan-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.513; GBOLAHXSUSFXOQ-UHFFFAOYSA-N; [M-H]-; N-({5-[6-(furan-2-yl)-2-methylpyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.507; FABJAUUGNRAJRD-UHFFFAOYSA-N; [M-H]-; N-{[5-(3-cyclopentyl-1-methyl-1H-pyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl}furan-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.486; INGUXUFDBQIFBA-UHFFFAOYSA-N; [M-H]-; N-({5-[6-(furan-2-yl)-2-methylpyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.481; IAFYNFFDTUUFOL-UHFFFAOYSA-N; [M-H]-; 4-(cyclohexylamino)-2-(hydroxymethyl)-3-{[2-(pyridin-3-yl)pyrimidin-4-yl]methyl}cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.414; NZNAOBRVCLBIHB-UHFFFAOYSA-N; [M-H]-; 4-[3-(diethylamino)propyl]-2-methyl-4,7,17-triazatetracyclo[8.7.0.0?,?.0??,??]heptadeca-1(10),11,13,15-tetraene-3,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QCWJONLQSHEGEJ-UHFFFAOYSA-N; [M-H]-; tetrofosmin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KTVATEBHFLZLCI-UHFFFAOYSA-N; [M-H]-; N,N''-hexane-1,6-diylbis[N'-benzylurea]
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.474; INJSHTCBZFXDQA-DAXSKMNVSA-N; [M-H]-; 4,5-dimethyl-2-[[(Z)-4-[3-(piperidin-1-ylmethyl)phenoxy]but-2-enyl]amino]-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; QCWJONLQSHEGEJ-UHFFFAOYSA-N; [M-H]-; 2-[bis(2-ethoxyethyl)phosphanyl]ethyl-bis(2-ethoxyethyl)phosphane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; KTVATEBHFLZLCI-UHFFFAOYSA-N; [M-H]-; 1-benzyl-3-[6-(benzylcarbamoylamino)hexyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.603; PZDUYAKJADSRGR-UHFFFAOYSA-N; [M-H]-; N-[3-(2-ethyl-4-oxoquinazolin-3-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.218; GZZUEBSQSDVIFT-UHFFFAOYSA-N; [M-H]-; 1-ethyl-3-[4-[3-(4-phenylpiperazin-1-yl)propoxy]phenyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; WYELOUDWFNJWCV-UHFFFAOYSA-N; [M-H]-; 1-methyl-3-[6-[[methyl(phenyl)carbamoyl]amino]hexyl]-1-phenylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.193; FQAOYYODGBRGRL; [M-H]-; 2-(2-Tetradecoxyethoxy)ethyl sulfate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.417; FQAOYYODGBRGRL; [M-H]-; 2-(2-Tetradecoxyethoxy)ethyl sulfate
COMMENT: CONFIDENCE Level 5: Exact mass of interest 381.231492; Observed in MS1; Charge state -1;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.008
MS$FOCUSED_ION: PRECURSOR_M/Z 381.231492
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000t-9307000000-4eff12be23e505b32a59
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  79.9559010 133.2745 ? 79.955890 0.5503 11.83 0.9530 48
  80.9637101 13.3250 ? 80.963700 1.2475 3.29 0.7997 44
  94.9794142 13.2856 ? 94.979420 1.2740 2.65 0.7922 44
  95.9508429 27.1704 ? 95.950850 1.2298 4.88 0.8920 47
  96.9586816 999.0000 ? 96.958690 0.4847 11.32 0.9695 48
  97.9299102 22.1933 ? 97.929920 1.0518 8.00 0.1607 39
  98.9544488 28.5866 ? 98.954460 1.1622 4.26 0.8765 46
  99.9243674 279.9572 ? 99.924380 0.4804 97.32 0.2754 48
  102.9278129 24.1027 ? 102.927830 1.0979 8.67 -0.2006 44
  113.9248545 11.4205 ? 113.924890 1.2815 4.26 0.0796 35
  115.9193609 144.0800 ? 115.919400 0.6211 53.81 0.1697 38
  118.9912300 16.2183 ? 118.991275 1.3278 13.62 0.4490 34
  122.9744670 49.8343 ? 122.974520 1.0978 6.12 0.9002 47
  173.9435129 25.7022 ? 173.943705 1.4085 9.81 0.1426 36
  174.9513544 16.8111 ? 174.951550 1.1546 6.34 0.0347 36
  176.8943577 23.6553 ? 176.894560 1.2154 8.68 -0.2561 42
  177.9021242 135.6094 ? 177.902330 0.6520 46.86 -0.0398 47
  178.9100756 13.1545 ? 178.910285 1.4365 5.23 -0.1474 34
  181.0071832 26.4460 ? 181.007400 1.0718 10.08 0.1868 35
  183.0109259 27.6956 ? 183.011150 1.3387 8.67 0.6048 35
  194.9059759 18.6620 ? 194.905400 1.3135 7.49 -0.1130 43
  201.9757333 36.9082 ? 201.975220 1.4012 15.36 0.0100 37
  214.9836729 53.5017 ? 214.983290 1.3396 18.46 0.2617 45
  312.1718213 33.2354 ? 312.172120 1.3550 10.88 0.4798 38
  381.2313752 930.5511 ? 381.231855 0.4617 61.32 1.0000 48
  382.2347493 188.1350 ? 382.235230 0.7561 16.00 0.9749 48
  382.9834837 156.3031 ? 382.983965 0.8721 58.53 0.1443 48
PK$NUM_PEAK: 27
PK$PEAK: m/z int. rel.int.
  79.955901 133.27 133
  80.963710 13.32 13
  94.979414 13.29 13
  95.950843 27.17 27
  96.958682 999.00 999
  97.929910 22.19 22
  98.954449 28.59 28
  99.924367 279.96 279
  102.927813 24.10 24
  113.924855 11.42 11
  115.919361 144.08 144
  118.991230 16.22 16
  122.974467 49.83 49
  173.943513 25.70 25
  174.951354 16.81 16
  176.894358 23.66 23
  177.902124 135.61 135
  178.910076 13.15 13
  181.007183 26.45 26
  183.010926 27.70 27
  194.905976 18.66 18
  201.975733 36.91 36
  214.983673 53.50 53
  312.171821 33.24 33
  381.231375 930.55 930
  382.234749 188.13 188
  382.983484 156.30 156
//
